🔎 Trials Near Me

Home › Arrhythmia › Texas › Austin

Arrhythmia clinical trials in Austin, TX

5 studies for Arrhythmia are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

Recruiting
  • Texas Cardiac Arrhythmia Research Foundation, Austin
Ages 18 to 85 · All sexes · Updated Sep 29, 2026 · NCT07585968

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

Recruiting
  • Texas Cardiac Arrhythmia Research Foundation, Austin
Ages 18 to 85 · All sexes · Updated Sep 3, 2026 · NCT06703489

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

RecruitingObservational studyHealthy volunteers welcome
  • Dell Children's Medical Center of Central Texas, Austin
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

RecruitingObservational study
  • Austin, Austin
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

RecruitingObservational studyHealthy volunteers welcome
  • Texas Cardiac Arrhythmia Research Foundation, Austin
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056

About Arrhythmia

If you have an arrhythmia, or irregular heartbeat, your heart may beat too quickly, too slowly, or with an irregular rhythm. Learn about causes and treatments.

More about Arrhythmia on MedlinePlus

Arrhythmia trials in other cities

Other studies in Austin

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.